, which upon refl uxing with sodium hydroxide, yielded the corresponding 1,2,4-triazole --3-thiols 8-10. Under acidic conditions, compounds 4-6 were converted to aminothiadiazoles 11-13. Moreover, the series of Schiff bases 14-18 were synthesized from the condensation of compound 3 with diff erent aromatic aldehydes. The newly synthesized compounds were characterized by IR, Literature survey reveals that several 1,2,4-triazole derivatives have been investigated as therapeutically interesting compounds due to the large diversity of their eff ects, such as anticonvulsant (3) , antimicrobial (4), analgesic (5), antioxidant (6) , anti-infl ammatory (7), pesticidal (8) , insecticidal (9) , herbicidal (10) and fungicidal ones (11) .
Compounds bearing 1,3,4-thiadiazole moieties have displayed a number of chemotherapeutic properties including antibacterial (12) , antifungal (13) , antitubercular (14) and analgesic ones (15) . On the other hand, Schiff bases are considered privileged structures in drug discovery, with signifi cant antimicrobial, antiviral, antifungal, antibacterial and anti-infl ammatory (16) (17) (18) (19) (20) activities as well as chelating properties towards various metal ions (21) .
Prompted by these observations and in continuation of our search on the synthesis of heterocyclic compounds containing nitrogen, sulfur and bicyclic systems with potential biological activity (22) (23) (24) , we have designed the synthesis of a novel series of imidazole derivatives. In particular, we emphasized the strategy of combining chemically diff erent but pharmacologically compatible molecules (the imidazole nucleus and the 1,2,4-triazole, 1,3,4-thiadiazole and/or Schiff base moiety) in one frame in order to study their antifungal and antibacterial activities.
EXPERIMENTAL

General
Melting points were determined on a variable heater (Stuart, UK) Melt-temp apparatus and are uncorrected. Percoated silica gel (Kieselgel, 0.25 mm, 60 F254, Merck, Germany) were used for thin layer chromatography. A developing solvent system of ethyl acetate/ hexane (1/2) was used and the spots were detected by ultraviolet light. NMR spectra were measured with a Bruker 400 MHz ( 13 C: 100 MHz) spectrometer (Bruker, Switzerland). Chemical shi s are expressed in d-values (ppm) relative to TMS as an internal standard, using DMSO-d 6 as a solvent. The IR spectra were measured in potassium bromide pellets using a Perkin-Elmer 1430 series FTIR spectrometer (Perkin-Elmer, USA). Full scan accurate mass spectra (mass range from 200 to 1500 Da) were obtained at high resolution [100,000, full-width half-maximum (FWHM) at 400 m/z] on a LTQ-FT Orbitrap Velos mass spectrometer (Thermo Electron GmbH, Germany). The hybrid mass spectrometer was equipped with a heated electrospray ionization (ESI) probe for the ion max source and operated in the positive mode. The electrospray source conditions were: capillary voltage 3.75 kV, heated capillary temperature 275 °C, source temperature 450 °C and S-Lens RF level 60 %. Nitrogen gas fl ows were set at 40 for the sheath gas and at 20 for the auxiliary gas, in arbitrary units. Elemental analyses were performed using an elementar Analysensysteme GmbH-Vario EL III Element Analyzer (Germany).
Syntheses
Ethyl (1,4,5-triphenylimidazol-2-yl) thiobutyrate (2) . -To a solution of compound 1 (3.281 g, 10 mmol) in DMF (15 mL), NaH (10 mmol) was added, followed by the addition of ethylbromobutyrate (1.506 g, 10 mmol). The mixture was heated under refl ux for 8 h, then cooled and poured onto crushed ice. The product was collected by fi ltration, washed with water, dried and recrystallized from ethanol.
(1,4,5-Triphenylimidazol-2-ylthio)butyric acid hydrazide (3). -A mixture of compound 2 (4.425 g, 10 mmol) and hydrazine hydrate (10 mmol) in ethanol (25 mL) was refl uxed for 10 h. A er cooling to room temperature, ethanol was removed under reduced pressure, and the product was recrystallized from ethanol. (1,4,5-triphenylimidazol-2-yl) thiopropyl]-2H-1,2,4-triazole-3-thione (4). -Carbon disulfi de (1.14 g, 15 mmol) was added dropwise to a solution of compound 3 (4.281 g, 10 mmol) in absolute ethanol (30 mL) containing potassium hydroxide (0.84 g, 15 mmol) at 0 °C. The reaction mixture was stirred at room temperature for 16 h, and then cooled and diluted with diethyl ether. The precipitate was fi ltered, washed with diethyl ether and dried. The potassium dithiocarbazinate salt was obtained in nearly quantitative yield and was used without further purifi cation since it was moisture sensitive.
4-Amino-5-[
Hydrazine hydrate (20 mmol) was added to a suspension of the potassium salt of dithiocarbazinate (10 mmol) in water (10 mL) and the mixture was refl uxed with stirring for 4 h. A er cooling, it was diluted with water, then acidifi ed with aqueous hydrochloric acid. The precipitate was fi ltered, washed with water and recrystallized from ethanol to give yellow needles.
-A mixture of compound 3 (4.281 g, 10 mmol) and the appropriate isothiocyanate derivative (10 mmol) was refl uxed in ethanol for 6 h. The solution was cooled and a white solid appeared. The obtained precipitate was fi ltered and recrystallized from ethanol to aff ord the desired product.
4-Alkyl/aryl-5-[(1,4,5-triphenylimidazol-2-yl)thiopropyl]-2H-1,2,4-triazole-3-thione (8-10).
General method. -A solution of the corresponding thiosemicarbazide 5-7 (10 mmol) in 100 mL of 4 mol L -1 NaOH was refl uxed for 8 h. The resulting solution was cooled to room temperature and acidifi ed with 37 % HCl. The precipitate formed was fi ltered, washed with water and recrystallized from ethanol to aff ord the desired product. (11) (12) (13) . General method. -A mixture of the corresponding thiosemicarbazide 5-7 (10 mmol) in cold concentrated sulfuric acid (20 mL) was stirred for 30 min. The mixture was then allowed to cool to room temperature. A er stirring for additional 3 h, the resulting solution was poured into ice-cold water and made alkaline to pH 8 with ammonia. The precipitated product was fi ltered and recrystallized from ethanol to aff ord the desired product. (14) (15) (16) (17) (18) . General method. -A mixture of compound 3 (0.428 g, 1 mmol) and the appropriate aromatic aldehyde (1 mmol) in ethanol (20 mL) and (0.5 mL) of HCl (37 %) was refl uxed for 4-6 h. A er cooling, the obtained product was collected and recrystallized from ethanol.
5-[(1,4,5-Triphenylimidazol-2-yl)thiopropyl]-2-(N-alkyl/arylamino)-1,3,4-thiadiazoles
4-[(1,4,5-Triphenylimidazol-2-yl)thio]-N'-(arylidene)-butanehydrazides
Physical, analytical data and spectral data (MS, IR, 
Antimicrobial susceptibility testing
The clinical isolate tested in this study were obtained from the culture collection maintained at the RCMB (Regional Center for Mycology and Biotechnology/Antimicrobial unit test organisms), Al Azhar University, Cairo-Egypt. All compounds were tested in vitro for their antibacterial activity against the following clinical bacterial strains: Gram negative bacteria, Escherichia coli (RCMB 0100520, Pseudomonas aeruginosa (RCMB 010043), and Gram positive bacteria, Streptococcus pneumonia (RCMB 010010), Bacillus subtilis (RCMB 010067) by the agar diff usion method (25) using Müller-Hinton agar medium for bacteria.
Antimicrobial susceptibility testing was performed by the agar disc-diff usion method. Sterile fi lter paper discs (8 mm diameter) were moistened with the compound solution in dimethylsulphoxide of specifi c concentration. Forty µL of the solution containing 200 µg of test compound or reference drug (gentamicin or ampicillin trihydrate) was loaded onto fi lter paper discs. Solvent was evaporated and discs were transferred to the inocu- lated plates. Loaded discs were carefully placed on Müller-Hinton for bacteria and Sabouraud's agar for fungi, previously inoculated separately with the test microorganisms. The plates were incubated at 37 o C for bacteria and 28 o C for fungi, diameters of the growth inhibition zones were measured a er 24 hours in case of bacteria and a er 48-96 hours in case of fungi. The antimicrobial activity was evaluated by measuring the zone of inhibition against the tested organisms and compared with that of the standards. Antimicrobial activities were expressed as the inhibition diameter zones in millimeters (mm) and are presented in Tables III and IV . Each experiment was carried out in triplicate and the average zone of inhibition was calculated.
Moreover, compounds 2-18 were also subjected to in vitro testing of antifungal activity against the following four clinical fungal strains: Aspergillus fumigatus (RCMB 02568), Syncephalastrum racemosum (RCMB 05922), Geotrichum candidum (RCMB 05097), and Candida albicans (RCMB 05031) by agar diff usion method (26) using Sabouraud's agar medium for fungi. 
Chemistry
Synthesis of the title azole compounds required stepwise reactions starting from 1,4,5-triphenylimidazole-2-thiol (1), as illustrated in Schemes 1-3. The starting compound 1 was prepared according to the literature (27) .
Alkylation of compound 1 with 4-ethylbromobutyrate in dimethylformamide in the presence of sodium hydride as a base gave ethyl(1,4,5-triphenylimidazol-2-yl)thiobutyrate (2) in 85 % yield. Hydrazinolysis of ester 2 with an equimolar amount of hydrazine hydrate furnished the corresponding acid hydrazide 3 (Scheme 1).
All the newly synthesized compounds were characterized by MS, IR, 1 H and 13 C NMR spectra. The structure of compound 2 was in accord with its spectroscopic data. The IR spectrum of compound 2 showed the principal absorption band at 1740 cm -1 , indicating the presence of a carbonyl group (C=O) in the molecule, which confi rms the success of the alkylation reaction. Table II ). All aromatic carbons of the three phenyl groups and C=N gave signals between d 126.19-142.35 ppm. In addition, the carbon of the carbonyl group appeared at d 172.38 ppm.
The IR spectrum of acid hydrazide 3 showed absorption bands at 3256-3380 cm -1 corresponding to the NH and NH 2 groups of the acid hydrazide, which confi rms the success of the hydrazinolysis reaction. The 1 H NMR spectrum of 3 showed a quintet around d 1.91-1.96 ppm due to the methylene group CH 2 CH 2 CH 2 . The remaining methylene groups of CH 2 CO and SCH 2 showed triplets at d 2.14 and 3.14 ppm, respectively. In addition, NH 2 and NH groups were assigned to two singlets appearing at d 4.16 and 9.00 ppm, respectively. The structure of 3 was also illustrated from its 13 H NMR and 13 C NMR spectra consistent with the assigned structures. In their IR spectra, the absorption peak corresponding to the C=N group was observed around 1642-1697 cm -1 . In their 1 H NMR spectra, the appearance of signals arising from the thiol group (SH) at d 13.52-13.74 ppm provided evidence for the formation of triazole ring. Another support for the structure of these compounds was the disappearance of resonances arising from -CONH and -NHCSNHaround d 7.88-9.90 ppm. The remaining protons were also observed in the expected regions (see Table II ).
Ring closure of acid thiosemicarbazides 5-7 in acidic medium is a well known method for the synthesis of 1,3,4-thiadiazoles (28) . Thus H NMR spectra of compounds 11-13 accounted for the thiadiazole ring formation and was reconfi rmed by the 13 C NMR peak at d 164.02-168.75 due to C2 of thiadiazole (see Table II ).
The acid hydrazide 3 was also condensed with various aromatic aldehydes in the presence of a catalytic amount of concentrated hydrochloric acid in refl uxing ethanol to aff ord a new series of Schiff bases 14-18 (Scheme 1).
It was reported in the literature (29, 30) that compounds having azomethine linkage exhibit E/Z geometrical isomerism around -C=N double bond and can exist as cis/trans amide conformers (30) . Moreover, hydrazones were proven exist in higher percentage in DMSO-d 6 solution in the form of geometrical E isomer.
The structures of the Schiff bases were in accord with their spectroscopic data. The IR spectra of compounds 14-17 showed the disappearance of the absorption bands of NH 2 groups and the appearance of strong absorption bands at 3254-3342 cm -1 a ributed to the NH. The 1 H and 13 C NMR spectra of hydrazones 14-18 clearly showed the disappearance of the NH 2 group of hydrazide structure and appearance of additional signals in the aromatic region belonging to the aldehydic protons.
The 1 H NMR spectra of compounds 14-18 revealed the presence of two sets of signals belonging to the SCH 2 and CH 2 CO groups of cis and trans conformers at 2.30-2.78 and 3.17-3.26 ppm, respectively, in a 0.4 to 0.6 ratio (Fig. 1) . Moreover, the azomethine CH proton and the amidic NH proton for compounds 15-18 resonated as two sets of signals at 8.10-8.90 and 11.30-11.77 ppm, respectively, with the same ratio. On the other hand, the appearance of these protons in the 1 H NMR spectrum of compound 14 as two sets of four singlets can be considered as a proof of the formation of the geometrical Z form in both cis and trans conformation. This can be explained by an intramolecular hydrogen bonding connecting the azomethine nitrogen and the OH group of the aldehyde side chain, favoured by a stable six-member ring.
The formation of E and Z forms could be a ributed to diff erent steric rearrangements of hydrazone functionality in the geometric syn and anti isomers resulting from the hindered rotation of azomethine linkage.
Further evidence can be found by comparing the 1 H NMR spectra of hydrazide 3 with hydrazones 14-18; no conformational equilibrium, under the same experimental conditions, was observed for hydrazide 3.
Therefore, the NMR spectra of compounds 14-18 recorded in DMSO-d 6 solution revealed that all compounds existed as E geometrical isomers, except compound 14 which exhibited both E/Z geometrical isomerisms. Moreover, the cis/trans conformers of E and Z isomers were also observed.
Biological activity
Antibacterial activity. -Ethyl(1,4,5-triphenylimidazol-2-yl)thiobutyrate (2) and its hydrazide derivative 3 displayed good activity against S. pneumonia and B. subtilis compared to the ampicillin reference and comparable activity against E. coli compared to gentamicin reference. Triazole 4, bearing amino and thiol groups, exhibited approximately equal antimicrobial activity against all tested microorganisms except P. aeruginosa.
The antimicrobial activity of the series 5-7 divulged compound 5, comprising phenyl substitution at N-4 exhibited the highest inhibition, whereas compounds 6 and 7 with alkyl substitution showed lower activity loss of inhibition against E. coli for compound 7.
Evaluation of the antimicrobial activity of the synthesized 4-alkyl/aryl-5-[(1,4,5-triphenylimidazol-2-yl)thiopropyl]-1,2,4-triazole-3-thiols 8-10 revealed that compounds were more eff ective against Gram positive bacteria. In particular, N-4 phenyl substituted triazole 8 exhibited activity against tested Gram positive bacteria comparable to its ampicillin reference and lower inhibition against E. coli against compared to gentamicin. In contrast, compound 10, comprising methyl substitution, displayed no activity against Gram negative organisms.
The mean values of inhibition zone diameters summarized in Table III show that compounds 11-13 possess congruent antibacterial activities against the growth of S. pneumonia, B. subtilis and E. coli compared to the standards ampicillin and gentamicin. Furthermore, N-phenyl thiadiazole 11 exhibited the highest antibacterial activity against all tested microorganisms, which can be a ributed to the presence of the thiadiazole ring.
Among the synthesized Schiff bases 14-18, compound 14, having 2-OH substitution on the phenyl ring, displayed the best antibacterial activity against S. pneumonia, B. subtilis and E. coli. However, compounds possessing unsubstituted and halosubstituted phenyl rings exhibited good to moderate activity.
Antifungal activity
In general, most of the tested compounds were found to possess signifi cant antifungal activity against all fungal strains except S. racemosum.
Compounds 2 and 3 exhibited lower antifungal activity against A. fumigatus, G. candidum and C. albicans compared to amphotericin B. The conversion of hydrazide structure 3 to 1,2,4-triazole functionalized with both thiol and amino groups caused congruent antifungal activity against A. fumigatus, G. candidum and C. albicans compared to the standard. On the other hand, 1-[4-(1,4,5-triphenylimidazol-2-ylthio)butanoyl]-4-phenyl/ethylthiosemicarbazides (5, 6) displayed remarkable antifungal activity, whereas their methyl analogue 7 displayed no activity against any of the fungal strains.
Contrary to what was expected, the cyclization of compounds 5-7 to their corresponding 1,2,4-triazoles (8-10) caused no enhancement of the antifungal activity. On the other hand, the antifungal activity of the 1,3,4-thiadiazoles 11-13 revealed that all the tested compounds showed signifi cant inhibition; compound 11 having phenyl substitution exhibited the highest activity. Thiadiazoles 12 and 13 showed comparatively lower activity against A. fumigatus, G. candidum and C. albicans compared to the standard.
In the studied Schiff bases series, 4-[(1,4,5-triphenylimidazol-2-yl)thio]-N'-(2-hydro xybenzylidene)-butanehydrazide (14) exhibited the highest antifungal activity against all fungal strains compared to amphotericin B.
CONCLUSIONS
In conclusion, a series of novel imidazole compounds bearing 1,2,4-triazole, 1,3,4-thiadiazole or Schiff base moieties were synthesized successfully via multistep synthesis. All the new compounds were fully spectroscopically characterized. The title compounds were synthesized as new compounds with antimicrobial activity in vitro.
